Danos Olivier (CIK 1701180) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-04-04). Recent activity: Sell RGNX (5,452 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-04 | REGENXBIO Inc. (RGNX) | Chief Scientific Officer | Sell | 5,452 | $43,998 |
Source: SEC Form 4 filings · as of 2025-04-04